| Literature DB >> 36217186 |
Virginia Fernandes Moça Trevisani1,2, Aysa César Pinheiro3, Sonia Cristina de Magalhães Souza Fialho4, Marilena Leal Mesquita Silvestre Fernandes5, Alisson Pugliesi6, Sandra Gofinet Pasoto7, Maria Lucia Lemos Lopes8, Lissiane Karine Noronha Guedes7, Samira Tatiyama Miyamoto9, Laura Caldas Dos Santos10, Simone Appenzeller6, Tania Fidelix10, Sandra Lúcia Euzébio Ribeiro11, Danielle Christinne Soares Egypto de Brito12, Tatiana Nayara Libório-Kimura13, Maria Carmen Lopes Ferreira Silva Santos14, Diego Ustárroz Cantali15, Juliana D 'Agostino Gennari16, Karina Gatz Capobianco17, Vinicius Tassoni Civile1, Ana Carolina Pereira Nunes Pinto1,18, Aline Pereira da Rocha1, César Ramos Rocha-Filho1, Fabiola Reis Oliveira19, Valeria Valim20.
Abstract
Sjogren's syndrome (SS) is an autoimmune disease characterized by lymphocytic infiltration of the exocrine glands and other organs, associated with sicca syndrome but also with systemic involvement with varying degrees of severity. Despite their importance, some systemic manifestations, mainly liver, gastrointestinal, and pancreatic are not routinely evaluated. To address these manifestations, the Sjögren's Syndrome Committee of the Brazilian Society of Rheumatology conducted a broad systematic review of the literature on studies investigating prevalence and diagnosis of these symptoms in Sjogren´s patients and made recommendations based on the findings. Agreement between the experts was achieved using the Delphi method. This is the second part of this guideline, providing 6 recommendations for liver, gastrointestinal, and pancreatic care of SS patients.Entities:
Keywords: Clinical guidelines; Gastrointestinal diseases; Sjögren’s syndrome
Mesh:
Year: 2022 PMID: 36217186 DOI: 10.1186/s42358-022-00267-y
Source DB: PubMed Journal: Adv Rheumatol ISSN: 2523-3106